S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.21
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CYRN stock logo

About Cyren Stock (NASDAQ:CYRN)

CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.

CYRN Stock News Headlines

Why Is Cyren (CYRN) Stock Down 27% Today?
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Cyren Announces Nasdaq Delisting Determination
Cyren Announces Liquidation
Why Is Cyren (CYRN) Stock Up 43% Today?
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Rutter points to Marsch influence
Cyren Ltd: Cyren Announces Third Quarter 2022 Financial Results
Cyren: Q3 Earnings Snapshot
Cyren Ltd (CYRN) Q3 2022 Earnings Call Transcript
Cyren Announces Third Quarter 2022 Financial Results
Cyren Inbox Security Achieves SOC 2 Type 2 Compliance
Cyren Announces Second Quarter 2022 Financial Results
See More Headlines
Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
Employees
200
Year Founded
1991

Profitability

Net Income
$-23,040,000.00
Net Margins
-123.96%
Pretax Margin
-94.37%

Debt

Sales & Book Value

Annual Sales
$31.19 million
Book Value
$3.05 per share

Miscellaneous

Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


CYRN Stock Analysis - Frequently Asked Questions

How were Cyren's earnings last quarter?

Cyren Ltd. (NASDAQ:CYRN) released its quarterly earnings data on Monday, November, 15th. The technology company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative net margin of 123.96% and a negative trailing twelve-month return on equity of 206.16%.

What other stocks do shareholders of Cyren own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Vaxart (VXRT), Biocept (BIOC), iBio (IBIO), MEI Pharma (MEIP), VBI Vaccines (VBIV) and

Does Cyren have any subsidiaries?
The following companies are subsidiares of Cyren: Authentium, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., Cyren UK Ltd., FRISK Software International, Wingtra, and eleven GmbH.
Read More
This page (NASDAQ:CYRN) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners